SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the Trump-themed meme coins steep decline from past highs and losses for holders, alongside election-related political debate. Many traders call it a scam or expect further downside, while a smaller bullish group says they are accumulating or anticipating a rebound.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter results, fueled by growth in Dupixent and Eylea HD, drove a sharp share-price jump and a new 52-week high. Traders are broadly bullish on the breakout and upside-leaning options activity, while watching legacy Eylea declines and questioning whether the momentum can hold.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Speculation around a suspected pneumonic plague incident in Russia has renewed interest in EBS as a biodefense supplier, with traders pointing to heavier volume and possible short covering. The outbreaks link to a lab remains unconfirmed, and some traders doubt the news will sustain the move amid ongoing concerns about the companys debt and business outlook.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,617.445402. The last known price of Zebec Network is 0.00197998 USD and is down -2.97 over the last 24 hours. It is currently trading on 133 active market(s) with $9,512,697.44 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Zebecs payments expansionespecially the MoneyGram-linked Stellar integrationis drawing attention, alongside discussion of Robinhood Chain support and European payroll deployments. Bulls view these developments as signs of growing real-world adoption, while skeptics argue that partnerships have yet to translate into sustained usage or token demand; separate Robinhood and BlackRock rumors remain unconfirmed.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is selling off despite a strong Q3 earnings beat as traders focus on its comparatively restrained Q4 outlook, margin and product-mix concerns, and elevated valuation. Some view the AI-driven testing demand and results as reasons to buy the pullback, while others see the outlook as insufficient to justify the stocks valuation.

3M Co. is a technology company, which engages in manufacturing industrial, safety, and consumer products. It operates through the following segments: Safety and Industrial, Transportation and Electronics, Consumer, and Corporate. The Safety and Industrial segment consists of personal safety, industrial adhesives and tapes, abrasives, closure and masking systems, electrical markets, automotive aftermarket, and roofing granules. The Transportation and Electronics segment includes electronics, automotive and aerospace, commercial solutions, advanced materials, and transportation safety. The Consumer segment covers consumer healthcare, home care, home improvement, and stationery and office products, such as consumer bandages, braces, supports, respirators, cleaning products, retail abrasives, picture hanging, and consumer air quality solutions. The Corporate segment refers to special items and other corporate expenses. The company was founded by Henry S. Bryan, Hermon W. Cable, John Dwan, William A. McGonagle, and J. Danley Budd in 1902 and is headquartered in St. Paul, MN.

3M Co.

3M is drawing attention after a quarterly earnings beat and raised full-year outlook alongside an expanded Amazon partnership tied to data-center products. Bulls see a turnaround and AI-infrastructure growth opportunity, while skeptics argue the partnership is conditional and the recent rally may fade; traders are also watching heavy options activity.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is under pressure as traders point to falling lithium prices and a bearish tilt in options flow, with most of the cited premium in puts. Ahead of earnings, the community is split between expecting further downside if lithium pricing and guidance disappoint and viewing the decline as a potential buying opportunity.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Discussion centers on newly presented soquelitinib data in atopic dermatitis and the sharp selloff that followed, despite bullish traders calling the results encouraging. Skeptics question the early-stage evidence and safety follow-up, while others blame unmet expectations from the investor presentation and point to short interest as possible pressure.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Call-heavy options activity has drawn attention to Lennar as homebuilders rebound, with some traders viewing the flow and easing yields as supportive. Others remain cautious about mortgage-rate and affordability pressures weighing on housing demand.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,559,996,383.70523. The last known price of Dogecoin is 0.07552377 USD and is down -0.48 over the last 24 hours. It is currently trading on 1543 active market(s) with $337,365,256.17 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention for its weakness and range-bound trading below the 8-cent level, with repeated chart commentary describing bearish or consolidating conditions. Traders are split between buying the dip and expecting further losses, while some tie recent pressure to a broader crypto selloff and Binance-hack fears.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet

IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance SheetPR NewswireVANCOUVER, BC and GLIL YAM, Israel, Sept. 29...

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares

IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common Shares IM Cannabis Announces Closing of US$1.31 Million Registered Direct Offering of Common SharesPR NewswireVANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026 VANCOUVER, BC and GLIL YAM, Israel, Sept. 24, 2026...

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement

IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireVANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the...

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares

IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common Shares IM Cannabis Announces Pricing of US$1.31 Million Registered Direct Offering of Common SharesPR NewswireVANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026 VANCOUVER, BC and GLIL YAM, Israel, Sept. 23, 2026...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million.
Vistagen Therapeutics (NASDAQ:VTGN) shares increased byread more...

IM Cannabis To Acquire 51% Of Space Defense Innovations, Stock Surges In Pre-Market

(RTTNews) - Wednesday, IM Cannabis Corp. (IMCC) announced a non-binding Letter of Intent to acquire 51% of the issued and outstanding equity securities of Space Defense Innovations LLC on a fully diluted basis...

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market

IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS Market IM Cannabis Enters Non-Binding Agreement to Acquire 51% of Space Defense Innovations, Operating in the European Tactical UAS MarketPR NewswireTORONTO and GLIL YAM...

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers

IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million.
SkyAI (NASDAQ:SKYA) stock rose 20.43% toread more...

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing PR Newswire TORONTO and GLIL YAM, Israel, Sept. 2, 2026 TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC...

IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis PR Newswire TORONTO and GLIL YAM, Israel, Aug. 27, 2026 TORONTO andGLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC...

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

IM Cannabis Corp

Retail Buzz Surges As IM Cannabis Plans Canadian Exchange Delisting; Investors Hope For Near 100% Rally

Equity

Neutral Sentiment

Retail chatter around IM Cannabis Corp. surged Wednesday after the company announced its request for voluntary delisting from the Canadian Securities Exchange (CSE).Shares of IM Cannabis surged 45.7% to close at $2.71 on Wednesday, before slipping slightly by 0.37% to $2.7 in after-hours trading.IM Cannabis said that its NASDAQ listing will remain unaffected by the CSE delisting, allowing shareholders to continue trading shares without disruptions.The company identified the high costs and administrative demands associated with regulatory approvals for dual listings as primary factors in its decision-making process.&nbsp;IM Cannabis said that focusing all its trading activity on NASDAQ will improve liquidity and create long-term shareholder value through a concentrated share market.If CSE approves the change, trading activity on the Canadian exchange will terminate post-business close on June 2.In the third quarter (Q3), IM Cannabis posted a 66% increase in revenue from the previous year in Germany, reaching CA$5.8 million ($4.1 million).&nbsp;The company recorded a 12% increase in total revenue, reaching CA$13.9 million ($10 million), compared to the previous year.&nbsp;It saved costs by reducing selling and marketing costs by 41% and cutting total operating expenses by 16%.&nbsp;Year-over-year core losses decreased by 68%, while the net loss declined by almost 50% to CA$1 million ($722,303).On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.One user anticipated the stock to reach $5 soon, with one user suggesting a move above $5 could happen as early as tomorrow.<stembedurl>https://stocktwits.com/hanoverfisteeDAD/message/616117911</stembedurl><stembedurl>https://stocktwits.com/hanoverfisteeDAD/message/616100340</stembedurl>The stock has risen nearly 19% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company revealed plans to delist from the Canadian Exchange, citing cost savings and improved liquidity on NASDAQ. 

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

$IMCC announced the closing of the sale of IMC Holdings and its European operations, strengthening its balance sheet.

jorge .miguel

$IMCC closing completely flat + burst of volume just before close. Could this thing actually go green to end the week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

IMCC IM Cannabis Corp

Fundamentals

Latest IMCC News